Mavrou Ariadni, Tsangaris George Th, Roma Eleftheria, Kolialexi Aggeliki
Department of Medical Genetics, Athens University School of Medicine, "Aghia Sofia" Childrens' Hospital, Thivon and Levadias, 115 27 Athens, Greece.
Anticancer Res. 2008 Jan-Feb;28(1B):401-5.
Ataxia telangiectasia (AT) is a rare neurodegenerative, autosomal recessive disorder characterized by chromosome instability, radiosensitivity, immunodeficiency and a predisposition for cancer. Epidemiological studies have shown that AT heterozygotes have a predisposition for cancer, especially for breast cancer in women. The disease is caused by mutations in the ATM gene, leading to total loss of the ATM protein, which normally recognizes DNA damage, activates the DNA repair machinery and the cell cycle check points in order to minimize the risk of genetic damage. This review summarizes the clinical features of AT and the natural history of the disease and puts recent molecular advances into the context of the cellular and clinical phenotype.
共济失调毛细血管扩张症(AT)是一种罕见的神经退行性常染色体隐性疾病,其特征为染色体不稳定、放射敏感性、免疫缺陷以及易患癌症。流行病学研究表明,AT杂合子易患癌症,尤其是女性乳腺癌。该疾病由ATM基因突变引起,导致ATM蛋白完全缺失,而ATM蛋白通常可识别DNA损伤,激活DNA修复机制和细胞周期检查点,以将遗传损伤风险降至最低。本综述总结了AT的临床特征和疾病自然史,并将近期的分子进展置于细胞和临床表型的背景下进行阐述。